Helicobacter pylori eradication and gastric cancer prevention in a pooled analysis of large-scale cohort studies in Japan
Helicobacter pylori ( H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40–74 years from f...
Saved in:
| Published in | Scientific reports Vol. 15; no. 1; pp. 21307 - 8 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.07.2025
Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Helicobacter pylori
(
H. pylori)
infection is an established cause of gastric cancer. Although
H. pylori
eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40–74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-
H. pylori
IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering
H. pylori
positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both
H. pylori
and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41–7.87) in those who were
H. pylori
-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18–2.57; 1y to < 6y: HR 0.81, 95%CI 0.59–1.11; ≥ 6y: HR 0.44, 95%CI 0.28–0.68). In this large Japanese general population,
H. pylori
eradication was associated with a long-term reduction in gastric cancer incidence. |
|---|---|
| AbstractList | Helicobacter pylori
(
H. pylori)
infection is an established cause of gastric cancer. Although
H. pylori
eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40–74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-
H. pylori
IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering
H. pylori
positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both
H. pylori
and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41–7.87) in those who were
H. pylori
-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18–2.57; 1y to < 6y: HR 0.81, 95%CI 0.59–1.11; ≥ 6y: HR 0.44, 95%CI 0.28–0.68). In this large Japanese general population,
H. pylori
eradication was associated with a long-term reduction in gastric cancer incidence. Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40-74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-H. pylori IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering H. pylori positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both H. pylori and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41-7.87) in those who were H. pylori-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18-2.57; 1y to < 6y: HR 0.81, 95%CI 0.59-1.11; ≥ 6y: HR 0.44, 95%CI 0.28-0.68). In this large Japanese general population, H. pylori eradication was associated with a long-term reduction in gastric cancer incidence.Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40-74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-H. pylori IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering H. pylori positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both H. pylori and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41-7.87) in those who were H. pylori-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18-2.57; 1y to < 6y: HR 0.81, 95%CI 0.59-1.11; ≥ 6y: HR 0.44, 95%CI 0.28-0.68). In this large Japanese general population, H. pylori eradication was associated with a long-term reduction in gastric cancer incidence. Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40-74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-H. pylori IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering H. pylori positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both H. pylori and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41-7.87) in those who were H. pylori-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18-2.57; 1y to < 6y: HR 0.81, 95%CI 0.59-1.11; ≥ 6y: HR 0.44, 95%CI 0.28-0.68). In this large Japanese general population, H. pylori eradication was associated with a long-term reduction in gastric cancer incidence. Abstract Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer risk, this has not been fully investigated in general populations. This analysis included 48,530 Japanese men and women aged 40–74 years from four cohort studies. At baseline, the participants provided a self-reported eradication history and serum anti-H. pylori IgG titers and the results of a pepsinogen (PG) test. We examined the association between eradication history and gastric cancer risk considering H. pylori positivity and PG testing using Cox proportional hazards regression models. From 2010 to 2018, 649 gastric cancer cases were diagnosed. Compared with those who were negative for both H. pylori and PG test as a reference, gastric cancer risk was 5.89 times higher (95%CI: 4.41–7.87) in those who were H. pylori-positive and/or PG test-positive and with no eradication at baseline. Gastric cancer risk among those who underwent eradication before baseline decreased after a temporal increase in risk following eradication (baseline to < 1y: HR 1.74, 95%CI 1.18–2.57; 1y to < 6y: HR 0.81, 95%CI 0.59–1.11; ≥ 6y: HR 0.44, 95%CI 0.28–0.68). In this large Japanese general population, H. pylori eradication was associated with a long-term reduction in gastric cancer incidence. |
| ArticleNumber | 21307 |
| Author | Tsugane, Shoichiro Sawada, Norie Inoue, Manami Ono, Ayami Tanaka, Shiori Ueno, Yoshiyuki Saito, Eiko Iwasaki, Motoki Abe, Yasuhiko Yamaji, Taiki Goto, Atsushi Yamagishi, Kazumasa Kayama, Takamasa Sasaki, Yu Muraki, Isao |
| Author_xml | – sequence: 1 givenname: Ayami surname: Ono fullname: Ono, Ayami organization: Division of Cohort Research, National Cancer Center Institute for Cancer Control – sequence: 2 givenname: Shiori surname: Tanaka fullname: Tanaka, Shiori organization: Division of Prevention, National Cancer Center Institute for Cancer Control – sequence: 3 givenname: Norie surname: Sawada fullname: Sawada, Norie organization: Division of Cohort Research, National Cancer Center Institute for Cancer Control – sequence: 4 givenname: Atsushi surname: Goto fullname: Goto, Atsushi organization: Department of Health Data Science, Graduate School of Data Science, Yokohama City University – sequence: 5 givenname: Shoichiro surname: Tsugane fullname: Tsugane, Shoichiro organization: Division of Cohort Research, National Cancer Center Institute for Cancer Control, International University of Health and Welfare Graduate School of Public Health – sequence: 6 givenname: Isao surname: Muraki fullname: Muraki, Isao organization: Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine – sequence: 7 givenname: Kazumasa surname: Yamagishi fullname: Yamagishi, Kazumasa organization: Department of Public Health Medicine, Institute of Medicine, and Health Services Research and Development Center, University of Tsukuba, Ibaraki Western Medical Center, Department of Public Health, Graduate School of Medicine, Juntendo University – sequence: 8 givenname: Yu surname: Sasaki fullname: Sasaki, Yu organization: Department of Gastroenterology, Faculty of Medicine, Yamagata University – sequence: 9 givenname: Yasuhiko surname: Abe fullname: Abe, Yasuhiko organization: Division of Endoscopy, Yamagata University Hospital – sequence: 10 givenname: Takamasa surname: Kayama fullname: Kayama, Takamasa organization: Institute for Promotion of Medical Science Research, Yamagata University – sequence: 11 givenname: Yoshiyuki surname: Ueno fullname: Ueno, Yoshiyuki organization: Department of Gastroenterology, Faculty of Medicine, Yamagata University, Institute for Promotion of Medical Science Research, Yamagata University – sequence: 12 givenname: Eiko surname: Saito fullname: Saito, Eiko organization: Sustainable Society Design Center, Graduate School of Frontier Science, The University of Tokyo – sequence: 13 givenname: Taiki surname: Yamaji fullname: Yamaji, Taiki organization: Division of Epidemiology, National Cancer Center Institute for Cancer Control – sequence: 14 givenname: Motoki surname: Iwasaki fullname: Iwasaki, Motoki organization: Division of Cohort Research, National Cancer Center Institute for Cancer Control, Division of Epidemiology, National Cancer Center Institute for Cancer Control – sequence: 15 givenname: Manami surname: Inoue fullname: Inoue, Manami email: mnminoue@ncc.go.jp organization: Division of Prevention, National Cancer Center Institute for Cancer Control |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40593877$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhi1UREvpH-CAcuQS8Fec-IRQBbSoEpfeLX9Mtl557WAnlba_vt5NqdoLPtiW53nfsWbmPTqJKQJCHwn-QjAbvhZOOjm0mHYtxj1h7cMbdEYx71rKKD15cT9FF6VscV0dlZzId-iU406yoe_P0P4KgrfJaDtDbqZ9SNk3kLXzVs8-xUZH12x0mbO3jdXRHqgM9xCPUV-BZkopgKukDvviS5PGJui8gbZYHaCx6S7luSnz4jyUg-S3nnT8gN6OOhS4eDrP0e3PH7eXV-3Nn1_Xl99vWsuFmFsHAiwfXUf7QQxuHJy1XNYKAOcCd0zIDjCMY-8oMQMx4BwhxHDGeyY0ZufoerV1SW_VlP1O571K2qvjQ8obpfPsbQBFuSSADTed5HXjpjeCY2EoUMl6IqrXt9VrWswOnK1FyDq8Mn0dif5ObdK9IpSS-lVaHT4_OeT0d4Eyq50vFkLQEdJSVG2XYB0VUlb008tkz1n-9a4CdAVsTqVkGJ8RgtVhRtQ6I6rOiDrOiHqoIraKSoXjBrLapiXXzpX_qR4BNVXAew |
| Cites_doi | 10.1002/ijc.29705 10.1055/s-0031-1291491 10.1158/1055-9965.EPI-05-0901 10.1038/s41598-021-95124-1 10.3322/caac.21834 10.1053/j.gastro.2016.01.028 10.2188/jea.JE20180182 10.1038/sj.bjc.6600775 10.1016/j.chom.2012.10.014 10.1007/s00535-017-1407-1 10.1136/bmjopen-2017-015855 10.1093/jjco/hyab055 10.1111/j.1349-7006.2003.tb01426.x 10.1007/s00535-010-0347-9 10.1038/jhg.2012.128 10.1016/j.chom.2021.04.006 10.2188/jea.JE20230168 10.1258/0969141041732184 10.1158/1055-9965.EPI-06-0436 10.1007/s10120-016-0658-5 10.1007/s10120-016-0650-0 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). The Author(s) 2025 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: The Author(s) 2025 2025 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1038/s41598-025-00713-z |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_2491e0b4b5944b54b7b6406b2e293716 PMC12215362 40593877 10_1038_s41598_025_00713_z |
| Genre | Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: National Cancer Center Research and Development Fund grantid: 23-A-31(toku), 26-A-2, 29-A-4; 23-A-31(toku), 26-A-2, 29-A-4 – fundername: Japan Agency for Medical Research and Development(AMED) grantid: 17ck0106277h0001,18ck0106277h0002,19ck0106277h0003,20ck0106561h0001,20ck0106561h0001RR,21ck0106561h0002,21ck0106561h0002RR,22ck0106561h0003, 22ck0106561h0003RR – fundername: the Japan Society for the Promotion of Science KAKENHI grantid: JP20K08350 – fundername: Research and Development by the Ministry of Education, Culture, Sports, Science, and Technology of Japan – fundername: National Cancer Center Research and Development Fund grantid: 23-A-31(toku), 26-A-2, 29-A-4 |
| GroupedDBID | 0R~ 4.4 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AASML ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M1P M2P M7P M~E NAO OK1 PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AAYXX CITATION PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c466t-de6ec4fd527868df8dcc49038e446053695e0eff7d21b81bedd111b434736a03 |
| IEDL.DBID | DOA |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:12:35 EDT 2025 Thu Aug 21 18:33:02 EDT 2025 Tue Aug 26 08:58:09 EDT 2025 Mon Jul 21 06:03:37 EDT 2025 Wed Aug 20 07:47:28 EDT 2025 Wed Jul 02 02:43:51 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Eradication Atrophic gastritis Gastric cancer Prospective cohort study Japan Helicobacter pylori |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c466t-de6ec4fd527868df8dcc49038e446053695e0eff7d21b81bedd111b434736a03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/2491e0b4b5944b54b7b6406b2e293716 |
| PMID | 40593877 |
| PQID | 3226352699 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2491e0b4b5944b54b7b6406b2e293716 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12215362 proquest_miscellaneous_3226352699 pubmed_primary_40593877 crossref_primary_10_1038_s41598_025_00713_z springer_journals_10_1038_s41598_025_00713_z |
| PublicationCentury | 2000 |
| PublicationDate | 2025-07-01 |
| PublicationDateYYYYMMDD | 2025-07-01 |
| PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2025 |
| Publisher | Nature Publishing Group UK Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Portfolio |
| References | H Suzuki (713_CR7) 2018; 53 F Bray (713_CR1) 2024; 74 A Fritz (713_CR15) 2000 K Nozaki (713_CR17) 2003; 94 M Inoue (713_CR4) 2017; 20 S Hiroi (713_CR24) 2017; 7 M Dinis-Ribeiro (713_CR23) 2012; 44 N Sawada (713_CR11) 2020; 30 T Nakajima (713_CR20) 2006; 15 S Imai (713_CR21) 2021; 29 H Tsugawa (713_CR22) 2012; 12 H Charvat (713_CR5) 2016; 138 713_CR3 713_CR2 Y Lin (713_CR9) 2021; 51 Y Sasaki (713_CR13) 2021; 11 S Sasazuki (713_CR6) 2006; 15 M Dinis-Ribeiro (713_CR12) 2004; 11 C Sauvaget (713_CR16) 2003; 88 M Maeda (713_CR19) 2017; 20 YC Lee (713_CR8) 2016; 150 H Narimatsu (713_CR10) 2013; 58 S Take (713_CR18) 2011; 46 T Kihara (713_CR14) 2024 |
| References_xml | – volume: 138 start-page: 320 year: 2016 ident: 713_CR5 publication-title: Int. J. Cancer doi: 10.1002/ijc.29705 – volume: 44 start-page: 74 year: 2012 ident: 713_CR23 publication-title: Endoscopy doi: 10.1055/s-0031-1291491 – volume: 15 start-page: 1341 year: 2006 ident: 713_CR6 publication-title: Cancer Epidemiol. Biomark. Prev doi: 10.1158/1055-9965.EPI-05-0901 – volume: 11 start-page: 15605 year: 2021 ident: 713_CR13 publication-title: Sci. Rep. doi: 10.1038/s41598-021-95124-1 – volume: 74 start-page: 229 year: 2024 ident: 713_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21834 – volume: 150 start-page: 1113 year: 2016 ident: 713_CR8 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.01.028 – volume: 30 start-page: 46 year: 2020 ident: 713_CR11 publication-title: J. Epidemiol. doi: 10.2188/jea.JE20180182 – volume: 88 start-page: 689 year: 2003 ident: 713_CR16 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6600775 – volume: 12 start-page: 764 year: 2012 ident: 713_CR22 publication-title: Cell Host Microb. doi: 10.1016/j.chom.2012.10.014 – volume: 53 start-page: 354 year: 2018 ident: 713_CR7 publication-title: J. Gastroenterol. doi: 10.1007/s00535-017-1407-1 – volume: 7 start-page: e015855 year: 2017 ident: 713_CR24 publication-title: BMJ Open doi: 10.1136/bmjopen-2017-015855 – volume-title: In International classification of diseases for oncology year: 2000 ident: 713_CR15 – ident: 713_CR3 – volume: 51 start-page: 1158 year: 2021 ident: 713_CR9 publication-title: Jpn. J. Clin. Oncol. doi: 10.1093/jjco/hyab055 – volume: 94 start-page: 235 year: 2003 ident: 713_CR17 publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2003.tb01426.x – volume: 46 start-page: 318 year: 2011 ident: 713_CR18 publication-title: J. Gastroenterol. doi: 10.1007/s00535-010-0347-9 – ident: 713_CR2 – volume: 58 start-page: 54 year: 2013 ident: 713_CR10 publication-title: J. Hum. Genet. doi: 10.1038/jhg.2012.128 – volume: 29 start-page: 941 year: 2021 ident: 713_CR21 publication-title: Cell Host Microb. doi: 10.1016/j.chom.2021.04.006 – year: 2024 ident: 713_CR14 publication-title: J. Epidemiol doi: 10.2188/jea.JE20230168 – volume: 11 start-page: 141 year: 2004 ident: 713_CR12 publication-title: J. Med. Screen doi: 10.1258/0969141041732184 – volume: 15 start-page: 2317 year: 2006 ident: 713_CR20 publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-06-0436 – volume: 20 start-page: 3 year: 2017 ident: 713_CR4 publication-title: Gastric Cancer doi: 10.1007/s10120-016-0658-5 – volume: 20 start-page: 8 year: 2017 ident: 713_CR19 publication-title: Gastric Cancer doi: 10.1007/s10120-016-0650-0 |
| SSID | ssj0000529419 |
| Score | 2.4516788 |
| Snippet | Helicobacter pylori
(
H. pylori)
infection is an established cause of gastric cancer. Although
H. pylori
eradication is suggested to decrease gastric cancer... Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric cancer... Abstract Helicobacter pylori (H. pylori) infection is an established cause of gastric cancer. Although H. pylori eradication is suggested to decrease gastric... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 21307 |
| SubjectTerms | 692/308/174 692/4028/67/1504/1829 692/4028/67/2195 692/4028/67/2322 692/499 Adult Aged Anti-Bacterial Agents - therapeutic use Antibodies, Bacterial - blood Atrophic gastritis Cohort Studies Eradication Female Gastric cancer Helicobacter Infections - complications Helicobacter Infections - drug therapy Helicobacter Infections - epidemiology Helicobacter Infections - microbiology Helicobacter pylori Helicobacter pylori - drug effects Humanities and Social Sciences Humans Japan Japan - epidemiology Male Middle Aged multidisciplinary Pepsinogen A - blood Prospective cohort study Risk Factors Science Science (multidisciplinary) Stomach Neoplasms - epidemiology Stomach Neoplasms - microbiology Stomach Neoplasms - prevention & control |
| SummonAdditionalLinks | – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEO-mBWQkbhCR-O3jgqiqPXChSL1ZdmyXlVC22mwP7a9n7CQrLVRIXHKIx4qTz_bMZMbfALxnQRgvNKtbnww6KE7XXjeuDlIol6RLNJUE2W_y_AdfXorLA6DzWZiStF8oLcs2PWeHfRpQ0eTDYFTUxbGq7x7AUaZqx7l9tFgsvy93f1Zy7Iq3Zjoh0zB9T-c9LVTI-u-zMP9OlPwjWlqU0NkTeDxZj2QxjvcpHMT-GTwc60nePodbVCKIrC8MzOQ6--IrEjcuTD_miOsDuXK5VEdHuow3Sk0cTti6QgGSa27FgJIjWQlZJ_IrZ4vXA6IZSS6ou9mSYUw_zF2WqG77F3Bx9vXiy3k91VaoOy7ltg5Rxo6nIKjSUoekQ9dxgx8r8hwpZdKI2MSUVKCtR9M2hoC7oueMKyZdw17CYb_u4zEQ5V1qhHYqth1vPNVCso4JiZ6viTLxCj7Mn9pejwwatkS-mbYjMBaBsQUYe1fB54zGTjKzX5cb682VnWaDRZexjY3nXhiOF-6Vl2iYeBpppveTFbybsbS4WnIIxPVxfTNY3L5krghgTAWvRmx3j-K5uqFWqgK9h_reWPZb-tXPwsjdUrSc0BSo4OM8Qey0Fwz_eNmT_xM_hUe0zOGcLPwaDrebm_gGTaKtfzutgd-3Ngji priority: 102 providerName: Springer Nature |
| Title | Helicobacter pylori eradication and gastric cancer prevention in a pooled analysis of large-scale cohort studies in Japan |
| URI | https://link.springer.com/article/10.1038/s41598-025-00713-z https://www.ncbi.nlm.nih.gov/pubmed/40593877 https://www.proquest.com/docview/3226352699 https://pubmed.ncbi.nlm.nih.gov/PMC12215362 https://doaj.org/article/2491e0b4b5944b54b7b6406b2e293716 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkLKu9AWRmJG0RN_PZxu2pV7aFCUKS9WXZsw0ooW222h_bXM7azVZeicuGSSLGj2P7Gnpl4_A1CH6nn2nFF69ZFDQ6KVbVTja294NJGYSOJOUD2TJx-Z_MFX9xK9ZViwgo9cBm4Q3AP2tA45rhmcGFOOgFKyJFAEpVbJtsGnXfLmSqs3kSzVo-nZBqqDgfQVOk0GeF19szq6x1NlAn7_2Zl3g2W_GPHNCuik330dLQg8bS0_Bl6EPrn6HHJKXn1Al2BIgF0XWZhxhfJH1_isLZ-_DmHbe_xD5vSdXS4S5hDrZHHCUqXUAGnvFvBQ81CWIJXEf9KEeP1AIgGnJLqrjd4KCGI6ZU5qNz-JTo_OT6fndZjfoW6Y0Jsah9E6Fj0nEgllI_Kdx3TMFiBpd1SKjQPTYhRetI6MG-D97AyOkaZpMI29BXa61d9eIOwdDY2XFkZ2o41jiguaEe5AO9XBxFZhT5th9pcFBYNk3e_qTIFGAPAmAyMua7QUULjpmZiwM4PQC7MKBfmX3JRoQ9bLA3MmLQNYvuwuhwMLGEiZQXQukKvC7Y3n2Ipw6GSskJqB_WdtuyW9MufmZW7JWA9gTlQoc9bATHjejDc09m3_6Oz79ATkiU7hREfoL3N-jK8B2Np4ybooVzICXo0nc6_zeF-dHz25Ss8nYnZJM-Z320wFS8 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKEFwQb8LTSHCCiMSvOAcOsFBtH_S0SL1ZdmyXlVC22myFtn_DnzJ2kpUWKiQOveSQTBzH8_aMZwBeMydqKxTLSxtqdFCMyq0qTO6kqEyQJtCQEmSP5fQbPzgRJzvwazwLk5L2U0nLJKbH7LD3HSqaeBiMijw5VvnFkEh56Nc_0U3rPux_Rpy-oXTvy2wyzYdOAnnDpVzlzkvf8OAErZRULijXNLwumPI8xgWZrIUvfAiVo6VFQ847hzLAcsYrJk3BcNhrcB1NexkZZyInm22cGCjjZT0cx8ERL5nplspLnQEuM2f_zsr8IzSbNN7eHbg9mKrkY784d2HHt_fgRt-8cn0f1qixkIxsKvdMzqLjPyd-adywC0hM68ipiX1BGtJE4kKooWAUPp0jAIkNvrxDyL4yClkE8iOmpucdko4nsXvvckW6PtcxvnKAur19ALOrWP6HsNsuWv8YSGVNKIQylS8bXliqhGQNExLd7NrLwDN4Oy61PuvLdegUZmdK94jRiBidEKMvMvgUsbGBjKW2043F8lQPpKfRPy19YbkVNccLt5WVaAVZ6mmsJSgzeDXiUiNrxniLaf3ivNMoK2VsP1DXGTzqcbv5FI-tFFVVZaC2sL41l-0n7fx7Kv9dUjTT0O7I4N1IIHoQPN0_fvbJ_4G_hJvT2dcjfbR_fPgUbtFEzzFL-Rnsrpbn_jnaYiv7InEDAX3F3PcbY8REAA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG_C00hwgpTEsR3nwGGhrNotqpAoUm-WHdtlJZRdbbZC2__D_2TsJCstVEgceskhmTiOv7FnxjOeAXhVWF4ZLos0N75CA0XL1MhMp1bwUnuhPfUxQPZYHHxj01N-ugO_hrMwMWg_prSMy_QQHfauRUETDoNRnkbDKr3YW1jfB1MeufVPNNXa94f7iOtrSiefTj4epH01gbRmQqxS64SrmbecllJI66Wta1ZlhXQs-AYLUXGXOe9LS3ODypyzFtcBwwpWFkJnBTZ7DXZRvc_ZCHbH4-nX6WYzJ7jLWF71h3KwzUv6uyX4Yn2Ay5Tav2Mz_3DQRrk3uQ23eoWVjLshugM7rrkL17sSlut7sEa5hcxkYtJnsgjm_4y4pbb9XiDRjSVnOlQHqUkdWAyp-rRR-HSGBCSU-XIWKbv8KGTuyY8QoJ62yECOhBq-yxVpu4jH8MoUJXxzH06uAoAHMGrmjXsEpDTaZ1zq0uU1ywyVXBR1wQUa25UTniXwZhhqteiSdqjobC-k6oBRCIyKwKiLBD4ENDaUIeF2vDFfnqmeARVaqbnLDDO8YnhhpjQCdSFDHQ0ZBUUCLwcsFU7Q4HXRjZuftwpXTBGKEFRVAg87bDefYqGgoizLBOQW6lt92X7SzL7HJOA5RWUNtY8E3g4Movrlp_3Hzz7-P_IXcOPL_kR9Pjw-egI3aWTnEKr8FEar5bl7hgrZyjzvpwMBdcUT8Ddyn0Zk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Helicobacter+pylori+eradication+and+gastric+cancer+prevention+in+a+pooled+analysis+of+large-scale+cohort+studies+in+Japan&rft.jtitle=Scientific+reports&rft.au=Ayami+Ono&rft.au=Shiori+Tanaka&rft.au=Norie+Sawada&rft.au=Atsushi+Goto&rft.date=2025-07-01&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1038%2Fs41598-025-00713-z&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2491e0b4b5944b54b7b6406b2e293716 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |